First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
Horn, Leora, Mansfield, Aaron S, Szczęsna, Aleksandra, Havel, Libor, Krzakowski, Maciej, Hochmair, Maximilian J, Huemer, Florian, Losonczy, György, Johnson, Melissa L, Nishio, Makoto, Reck, Martin, Mok, Tony, Lam, Sivuonthanh, Shames, David S, Liu, Juan, Ding, Beiying, Lopez-Chavez, Ariel, Kabbinavar, Fairooz, Lin, Wei, Sandler, Alan, Liu, Stephen V
Published in The New England journal of medicine (06.12.2018)
Published in The New England journal of medicine (06.12.2018)
Get full text
Journal Article
Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study
Goss, Glenwood, Dr Prof, Tsai, Chun-Ming, Prof, Shepherd, Frances A, Prof, Bazhenova, Lyudmila, Prof, Lee, Jong Seok, MD, Chang, Gee-Chen, MD, Crino, Lucio, MD, Satouchi, Miyako, MD, Chu, Quincy, MD, Hida, Toyoaki, MD, Han, Ji-Youn, Prof, Juan, Oscar, MD, Dunphy, Frank, Prof, Nishio, Makoto, MD, Kang, Jin-Hyoung, MD, Majem, Margarita, MD, Mann, Helen, MSc, Cantarini, Mireille, MD, Ghiorghiu, Serban, MD, Mitsudomi, Tetsuya, Prof
Published in The lancet oncology (01.12.2016)
Published in The lancet oncology (01.12.2016)
Get full text
Journal Article
Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non-small cell lung cancer
Gong, Bo, Kiyotani, Kazuma, Sakata, Seiji, Nagano, Seiji, Kumehara, Shun, Baba, Satoko, Besse, Benjamin, Yanagitani, Noriko, Friboulet, Luc, Nishio, Makoto, Takeuchi, Kengo, Kawamoto, Hiroshi, Fujita, Naoya, Katayama, Ryohei
Published in The Journal of experimental medicine (01.04.2019)
Published in The Journal of experimental medicine (01.04.2019)
Get full text
Journal Article
Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial
Nishio, Makoto, Barlesi, Fabrice, West, Howard, Ball, Simon, Bordoni, Rodolfo, Cobo, Manuel, Longeras, Pascale Dubray, Goldschmidt, Jerome, Novello, Silvia, Orlandi, Francisco, Sanborn, Rachel E., Szalai, Zsuzsanna, Ursol, Grigoriy, Mendus, Diana, Wang, Lijia, Wen, Xiaohui, McCleland, Mark, Hoang, Tien, Phan, See, Socinski, Mark A.
Published in Journal of thoracic oncology (01.04.2021)
Published in Journal of thoracic oncology (01.04.2021)
Get full text
Journal Article
Gilteritinib overcomes lorlatinib resistance in ALK-rearranged cancer
Mizuta, Hayato, Okada, Koutaroh, Araki, Mitsugu, Adachi, Jun, Takemoto, Ai, Kutkowska, Justyna, Maruyama, Kohei, Yanagitani, Noriko, Oh-hara, Tomoko, Watanabe, Kana, Tamai, Keiichi, Friboulet, Luc, Katayama, Kazuhiro, Ma, Biao, Sasakura, Yoko, Sagae, Yukari, Kukimoto-Niino, Mutsuko, Shirouzu, Mikako, Takagi, Satoshi, Simizu, Siro, Nishio, Makoto, Okuno, Yasushi, Fujita, Naoya, Katayama, Ryohei
Published in Nature communications (24.02.2021)
Published in Nature communications (24.02.2021)
Get full text
Journal Article
Capmatinib in MET Exon 14–Mutated or MET-Amplified Non–Small-Cell Lung Cancer
Wolf, Jürgen, Seto, Takashi, Han, Ji-Youn, Reguart, Noemi, Garon, Edward B, Groen, Harry J.M, Tan, Daniel S.W, Hida, Toyoaki, de Jonge, Maja, Orlov, Sergey V, Smit, Egbert F, Souquet, Pierre-Jean, Vansteenkiste, Johan, Hochmair, Maximilian, Felip, Enriqueta, Nishio, Makoto, Thomas, Michael, Ohashi, Kadoaki, Toyozawa, Ryo, Overbeck, Tobias R, de Marinis, Filippo, Kim, Tae-Min, Laack, Eckart, Robeva, Anna, Le Mouhaer, Sylvie, Waldron-Lynch, Maeve, Sankaran, Banu, Balbin, O. Alejandro, Cui, Xiaoming, Giovannini, Monica, Akimov, Mikhail, Heist, Rebecca S
Published in The New England journal of medicine (03.09.2020)
Published in The New England journal of medicine (03.09.2020)
Get full text
Journal Article
Alectinib versus crizotinib in patients with ALK -positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial
Hida, Toyoaki, MD, Nokihara, Hiroshi, MD, Kondo, Masashi, MD, Kim, Young Hak, MD, Azuma, Koichi, MD, Seto, Takashi, MD, Takiguchi, Yuichi, Prof, Nishio, Makoto, MD, Yoshioka, Hiroshige, MD, Imamura, Fumio, MD, Hotta, Katsuyuki, Prof, Watanabe, Satoshi, MD, Goto, Koichi, MD, Satouchi, Miyako, MD, Kozuki, Toshiyuki, MD, Shukuya, Takehito, MD, Nakagawa, Kazuhiko, Prof, Mitsudomi, Tetsuya, Prof, Yamamoto, Nobuyuki, Prof, Asakawa, Takashi, PhD, Asabe, Ryoichi, MS, Tanaka, Tomohiro, MS, Tamura, Tomohide, Dr
Published in The Lancet (British edition) (01.07.2017)
Published in The Lancet (British edition) (01.07.2017)
Get full text
Journal Article
Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial
Takahashi, Toshiaki, MD, Yamanaka, Takeharu, Prof, Seto, Takashi, MD, Harada, Hideyuki, MD, Nokihara, Hiroshi, MD, Saka, Hideo, MD, Nishio, Makoto, MD, Kaneda, Hiroyasu, MD, Takayama, Koichi, MD, Ishimoto, Osamu, MD, Takeda, Koji, MD, Yoshioka, Hiroshige, MD, Tachihara, Motoko, MD, Sakai, Hiroshi, MD, Goto, Koichi, MD, Yamamoto, Nobuyuki, Prof
Published in The lancet oncology (01.05.2017)
Published in The lancet oncology (01.05.2017)
Get full text
Journal Article
Ceritinib versus chemotherapy in patients with ALK -rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial
Shaw, Alice T, Dr, Kim, Tae Min, MD, Crinò, Lucio, Prof, Gridelli, Cesare, MD, Kiura, Katsuyuki, MD, Liu, Geoffrey, MD, Novello, Silvia, Prof, Bearz, Alessandra, MD, Gautschi, Oliver, MD, Mok, Tony, Prof, Nishio, Makoto, MD, Scagliotti, Giorgio, Prof, Spigel, David R, MD, Deudon, Stéphanie, PharmD, Zheng, Cheng, PhD, Pantano, Serafino, PhD, Urban, Patrick, MD, Massacesi, Cristian, MD, Viraswami-Appanna, Kalyanee, PhD, Felip, Enriqueta, MD
Published in The lancet oncology (01.07.2017)
Published in The lancet oncology (01.07.2017)
Get full text
Journal Article
Pembrolizumab plus pemetrexed‐platinum for metastatic nonsquamous non–small‐cell lung cancer: KEYNOTE‐189 Japan Study
Horinouchi, Hidehito, Nogami, Naoyuki, Saka, Hideo, Nishio, Makoto, Tokito, Takaaki, Takahashi, Toshiaki, Kasahara, Kazuo, Hattori, Yoshihiro, Ichihara, Eiki, Adachi, Noriaki, Noguchi, Kazuo, Souza, Fabricio, Kurata, Takayasu
Published in Cancer science (01.08.2021)
Published in Cancer science (01.08.2021)
Get full text
Journal Article
Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study
Seto, Takashi, MD, Kato, Terufumi, MD, Nishio, Makoto, MD, Goto, Koichi, MD, Atagi, Shinji, MD, Hosomi, Yukio, MD, Yamamoto, Noboru, MD, Hida, Toyoaki, MD, Maemondo, Makoto, MD, Nakagawa, Kazuhiko, Prof, Nagase, Seisuke, MD, Okamoto, Isamu, MD, Yamanaka, Takeharu, PhD, Tajima, Kosei, MSc, Harada, Ryosuke, BS, Fukuoka, Masahiro, MD, Yamamoto, Nobuyuki, Prof
Published in The lancet oncology (01.10.2014)
Published in The lancet oncology (01.10.2014)
Get full text
Journal Article
IMpower132: Atezolizumab plus platinum‐based chemotherapy vs chemotherapy for advanced NSCLC in Japanese patients
Nishio, Makoto, Saito, Haruhiro, Goto, Koichi, Watanabe, Satoshi, Sueoka‐Aragane, Naoko, Okuma, Yusuke, Kasahara, Kazuo, Chikamori, Kenichi, Nakagawa, Yuki, Kawakami, Tomohisa
Published in Cancer science (01.04.2021)
Published in Cancer science (01.04.2021)
Get full text
Journal Article
Drug resistance mechanisms in Japanese anaplastic lymphoma kinase‐positive non–small cell lung cancer and the clinical responses based on the resistant mechanisms
Yanagitani, Noriko, Uchibori, Ken, Koike, Sumie, Tsukahara, Mika, Kitazono, Satoru, Yoshizawa, Takahiro, Horiike, Atsushi, Ohyanagi, Fumiyoshi, Tambo, Yuichi, Nishikawa, Shingo, Fujita, Naoya, Katayama, Ryohei, Nishio, Makoto
Published in Cancer science (01.03.2020)
Published in Cancer science (01.03.2020)
Get full text
Journal Article
Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, EGFR -Mutated Non-Small Cell Lung Cancer
Jänne, Pasi A, Baik, Christina, Su, Wu-Chou, Johnson, Melissa L, Hayashi, Hidetoshi, Nishio, Makoto, Kim, Dong-Wan, Koczywas, Marianna, Gold, Kathryn A, Steuer, Conor E, Murakami, Haruyasu, Yang, James Chih-Hsin, Kim, Sang-We, Vigliotti, Michele, Shi, Rong, Qi, Zhenhao, Qiu, Yang, Zhao, Lihui, Sternberg, David, Yu, Channing, Yu, Helena A
Published in Cancer discovery (01.01.2022)
Published in Cancer discovery (01.01.2022)
Get full text
Journal Article
Single-arm, multicentre, phase II trial of nivolumab for unresectable or recurrent thymic carcinoma: PRIMER study
Katsuya, Yuki, Horinouchi, Hidehito, Seto, Takashi, Umemura, Shigeki, Hosomi, Yukio, Satouchi, Miyako, Nishio, Makoto, Kozuki, Toshiyuki, Hida, Toyoaki, Sukigara, Tamie, Nakamura, Kenichi, Kuchiba, Aya, Ohe, Yuichiro
Published in European journal of cancer (1990) (01.05.2019)
Published in European journal of cancer (1990) (01.05.2019)
Get full text
Journal Article
Analysis of central nervous system efficacy in the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer
Nishio, Makoto, Nakagawa, Kazuhiko, Mitsudomi, Tetsuya, Yamamoto, Nobuyuki, Tanaka, Tomohiro, Kuriki, Hiroshi, Zeaiter, Ali, Tamura, Tomohide
Published in Lung cancer (Amsterdam, Netherlands) (01.07.2018)
Published in Lung cancer (Amsterdam, Netherlands) (01.07.2018)
Get full text
Journal Article
Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer
Nakagawa, Kazuhiko, Hida, Toyoaki, Nokihara, Hiroshi, Morise, Masahiro, Azuma, Koichi, Kim, Young Hak, Seto, Takashi, Takiguchi, Yuichi, Nishio, Makoto, Yoshioka, Hiroshige, Kumagai, Toru, Hotta, Katsuyuki, Watanabe, Satoshi, Goto, Koichi, Satouchi, Miyako, Kozuki, Toshiyuki, Koyama, Ryo, Mitsudomi, Tetsuya, Yamamoto, Nobuyuki, Asakawa, Takashi, Hayashi, Morihiko, Hasegawa, Wakako, Tamura, Tomohide
Published in Lung cancer (Amsterdam, Netherlands) (01.01.2020)
Published in Lung cancer (Amsterdam, Netherlands) (01.01.2020)
Get full text
Journal Article
CH5424802 (RO5424802) for patients with ALK -rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1–2 study
Seto, Takashi, MD, Kiura, Katsuyuki, Prof, Nishio, Makoto, MD, Nakagawa, Kazuhiko, Prof, Maemondo, Makoto, MD, Inoue, Akira, MD, Hida, Toyoaki, MD, Yamamoto, Nobuyuki, MD, Yoshioka, Hiroshige, MD, Harada, Masao, MD, Ohe, Yuichiro, MD, Nogami, Naoyuki, MD, Takeuchi, Kengo, MD, Shimada, Tadashi, MS, Tanaka, Tomohiro, MS, Tamura, Tomohide, Dr
Published in The lancet oncology (01.06.2013)
Published in The lancet oncology (01.06.2013)
Get full text
Journal Article
The new-generation selective ROS1/NTRK inhibitor DS-6051b overcomes crizotinib resistant ROS1-G2032R mutation in preclinical models
Katayama, Ryohei, Gong, Bo, Togashi, Noriko, Miyamoto, Masaya, Kiga, Masaki, Iwasaki, Shiho, Kamai, Yasuki, Tominaga, Yuichi, Takeda, Yasuyuki, Kagoshima, Yoshiko, Shimizu, Yuki, Seto, Yosuke, Oh-hara, Tomoko, Koike, Sumie, Nakao, Naoki, Hanzawa, Hiroyuki, Watanabe, Kengo, Yoda, Satoshi, Yanagitani, Noriko, Hata, Aaron N., Shaw, Alice T., Nishio, Makoto, Fujita, Naoya, Isoyama, Takeshi
Published in Nature communications (09.08.2019)
Published in Nature communications (09.08.2019)
Get full text
Journal Article
Podoplanin enhances lung cancer cell growth in vivo by inducing platelet aggregation
Miyata, Kenichi, Takemoto, Ai, Okumura, Sakae, Nishio, Makoto, Fujita, Naoya
Published in Scientific reports (22.06.2017)
Published in Scientific reports (22.06.2017)
Get full text
Journal Article